Molecular dynamics simulation of HIV-1 protease in a crystalline environment and in solution.

Simulations of the unbound form of the human immunodeficiency virus type 1 protease have been carried out to 200 ps in a crystalline environment and in solution. Solution simulations were performed with and without charge-balancing counterions. The results are compared with the 2.8-A crystallographic structure of Wlodawer et al. [(1989) Science 245, 616], and a proposed model for the solution structure which involves local refolding of the flap regions is presented. The simulations suggest the crystal packing environment of the protease dimer stabilizes the flaps in an extended conformation. Solvation of the dimer leads to local refolding of the flaps which contract toward the active site, forming increased overlap and stronger intersubunit hydrogn bonding at the tips. The degree to which the flaps overlap in solution is observed to depend on the charge state of the system.

[1]  J N Weinstein,et al.  Relative differences in the binding free energies of human immunodeficiency virus 1 protease inhibitors: a thermodynamic cycle-perturbation approach. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Meek,et al.  Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. , 1991, Biochemistry.

[3]  U. C. Singh,et al.  Free energy perturbation studies on inhibitor binding to HIV-1 proteinase , 1992 .

[4]  J A McCammon,et al.  Theoretical calculation of relative binding affinity in host-guest systems. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Norbeck,et al.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.

[6]  P. Kollman,et al.  An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.

[7]  M. Karplus,et al.  Anisotropy and anharmonicity of atomic fluctuations in proteins: Analysis of a molecular dynamics simulation , 1987, Proteins.

[8]  V. Turk,et al.  Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  John P. Overington,et al.  X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes , 1989, Nature.

[10]  R. Dixon,et al.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution. , 1991, The Journal of biological chemistry.

[11]  M. Karplus,et al.  Molecular dynamics simulations in biology , 1990, Nature.

[12]  C. Debouck,et al.  Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  O. Tapia,et al.  Structure and fluctuations of bacteriophage T4 glutaredoxin modelled by molecular dynamics. , 1990, Biochemical and biophysical research communications.

[14]  B. Dunn,et al.  Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinases , 1989, FEBS letters.

[15]  Maria Miller,et al.  Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.

[16]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[17]  Bernard Pettitt,et al.  Peptides in ionic solutions: A comparison of the Ewald and switching function techniques , 1991 .

[18]  O. Steinhauser,et al.  Cutoff size does strongly influence molecular dynamics results on solvated polypeptides. , 1992, Biochemistry.

[19]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[20]  P A Kollman,et al.  Determination of the relative binding free energies of peptide inhibitors to the HIV-1 protease. , 1991, Journal of medicinal chemistry.

[21]  A Wlodawer,et al.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution. , 1989, Science.

[22]  T L Blundell,et al.  Domain flexibility in aspartic proteinases , 1992, Proteins.

[23]  I. Weber,et al.  Comparison of inhibitor binding in HIV‐1 protease and in non‐viral aspartic proteases: the role of the flap , 1990, FEBS letters.

[24]  S. Swaminathan,et al.  Investigation of domain structure in proteins via molecular dynamics simulation: application to HIV-1 protease dimer , 1991 .

[25]  M. Katharine Holloway,et al.  X-Ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C2 Symmetry , 1991 .

[26]  A Wlodawer,et al.  X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Brooks,et al.  The effects of truncating long‐range forces on protein dynamics , 1989, Proteins.

[28]  A Wlodawer,et al.  Molecular modeling of the HIV-1 protease and its substrate binding site. , 1989, Science.

[29]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[30]  T. Darden,et al.  Simulation of the solution structure of the H-ras p21-GTP complex. , 1992, Biochemistry.

[31]  A. Bax,et al.  Two-dimensional NMR and protein structure. , 1989, Annual review of biochemistry.

[32]  M. Manneberg,et al.  Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase. , 1990, Biochemical and biophysical research communications.

[33]  J. Louis,et al.  The effect of salt on the Michaelis Menten constant of the HIV‐1 protease correlates with the Hofmeister series , 1991, FEBS letters.

[34]  I. Weber.  Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases. , 1990, The Journal of biological chemistry.

[35]  Marianne Manchester,et al.  Complete mutagenesis of the HIV-1 protease , 1989, Nature.

[36]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[37]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[38]  L J Davis,et al.  Active human immunodeficiency virus protease is required for viral infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H Toh,et al.  Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus. , 1985, The EMBO journal.

[40]  C. Debouck,et al.  The HIV-1 protease as a therapeutic target for AIDS. , 1992, AIDS research and human retroviruses.

[41]  A Wlodawer,et al.  Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.

[42]  C. Debouck,et al.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Dixon,et al.  Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease. , 1989, The Journal of biological chemistry.

[44]  J. C. Martin,et al.  Domain communication in the dynamical structure of human immunodeficiency virus 1 protease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Gronenborn,et al.  Crystal structure of interleukin 8: symbiosis of NMR and crystallography. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Jaskólski,et al.  Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution. , 1989, Biochemistry.

[47]  S. Swaminathan,et al.  Molecular dynamics of HIV‐1 protease , 1992, Proteins.